marginally significantP = 0.05
Notably, for non-HDL-C variability, Q4 also showed a marginally significant increase in risk (aHR = 2.50, 95% CI: 1.01–6.15, P = 0.05).
Notably, for non-HDL-C variability, Q4 also showed a marginally significant increase in risk (aHR = 2.50, 95% CI: 1.01–6.15, P = 0.05).